Miri Wernli
President at MIND MEDICINE (MINDMED) INC.
Net worth: 767 163 $ as of 31/03/2024
Profile
Miri Halperin Wernli is the founder of Melodiol Global Health Ltd., which was founded in 2015.
She held the title of Group CEO, Managing Director & Executive Director at the company.
Currently, Dr. Wernli is the Executive President at Mind Medicine (MindMed), Inc., starting in 2020.
In her former position, she was the Vice President at Actelion Pharmaceuticals US, Inc. from 2007 to 2016.
Dr. Wernli has an MBA from Stanford University and a doctorate from the University of Geneva.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
27/02/2024 | 81,353 ( 0.12% ) | 764 718 $ | 31/03/2024 | |
29/03/2023 | 750,000 ( 0.18% ) | 2 445 $ | 31/03/2024 |
Miri Wernli active positions
Companies | Position | Start |
---|---|---|
MIND MEDICINE (MINDMED) INC. | President | 01/02/2021 |
Former positions of Miri Wernli
Companies | Position | End |
---|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01/01/2016 |
MELODIOL GLOBAL HEALTH LIMITED | Chief Executive Officer | 15/08/2020 |
Training of Miri Wernli
Stanford University | Masters Business Admin |
University of Geneva | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
MELODIOL GLOBAL HEALTH LIMITED | Health Technology |
MIND MEDICINE (MINDMED) INC. | Health Technology |
Private companies | 1 |
---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
- Stock Market
- Insiders
- Miri Wernli